tranexamic acid has been researched along with Carcinoma, Renal Cell in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, D | 1 |
| Mishra, S | 1 |
| Bhatnagar, S | 1 |
| Jain, V | 1 |
| Gamanagatti, S | 1 |
1 other study available for tranexamic acid and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Trial of angioembolization of advanced stage tumors feeding arteries exemplifying aggressive and active interventional palliation.
Topics: Aminocaproates; Antifibrinolytic Agents; Carcinoma, Renal Cell; Embolization, Therapeutic; Humans; K | 2008 |